Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of largely unknown pathophysiology, characterized by the progressive loss of motoneurons (MNs). We review data showing that in presymptomatic ALS mice, MNs display reduced intrinsic excitability and impaired level of excitatory inputs. The loss of repetitive firing specifically affects the large MNs innervating fast contracting muscle fibers, which are the most vulnerable MNs in ALS. Interventions that aimed at restoring either the intrinsic excitability or the synaptic excitation result in a decrease of disease markers in MNs and delayed neuromuscular junction denervation. We then focus on trans‐spinal direct current stimulation (tsDCS), a noninvasive tool, since it modulates the activity of spinal neurons and networks. Effects of tsDCS depend on the polarity of applied current. Recent work shows that anodal tsDCS induces long‐lasting enhancement of MN excitability and synaptic excitation of spinal MNs. Moreover, we show preliminary results indicating that anodal tsDCS enhances the excitatory synaptic inputs to MNs in ALS mice. In conclusion, we suggest that chronic application of anodal tsDCS might be useful as a complementary method in the management of ALS patients.
Highlights
Recent data demonstrate that the excitability changes of spinal motoneurons (MNs) in amyotrophic lateral sclerosis (ALS, a prominent neurodegenerative disease of MNs) depend on the physiological type of motor unit and evolve with disease progression
We review recent work suggesting that trans-spinal direct current stimulation (tsDCS) could be used to compensate for the changes in intrinsic excitability of MNs, or synaptic excitation, and hopefully to deliver some neuroprotection in Amyotrophic lateral sclerosis (ALS)
Recent experiments suggest that vulnerable MNs become intrinsically hypoexcitable and that their excitatory synapses are impaired in the SOD1G93A mice
Summary
Recent data demonstrate that the excitability changes of spinal motoneurons (MNs) in amyotrophic lateral sclerosis (ALS, a prominent neurodegenerative disease of MNs) depend on the physiological type of motor unit and evolve with disease progression. We review recent work suggesting that tsDCS could be used to compensate for the changes in intrinsic excitability of MNs, or synaptic excitation, and hopefully to deliver some neuroprotection in ALS. In ALS mouse models, time-dependent alterations of intrinsic MN excitability that start long before degeneration onset have been shown in both vulnerable and resistant MNs. In these studies it was found that MNs are hyperexcitable at embryonic stages in the SOD1 G93Amice (input resistance is increased, rheobase is decreased and slope of the frequency–current relationship is increased; Martin et al, 2013; Pieri et al, 2003).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.